Literature DB >> 7427942

Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis.

L Dobrossy, Z P Pavelic, M Vaughan, N Porter, R J Bernacki.   

Abstract

Lysosomal enzymes were elevated about two-fold in primary s.c. Lewis lung carcinoma as compared with metastatic nodules in the lung. In a time course experiment, a general two-fold elevation of acid phosphatase and several glycosidases was observed in the primary tumor between the 14th and 17th postimplant day following s.c. inoculation of Lewis lung carcinoma. This increase in hydrolytic enzyme activity was not due to necrosis in the primary tumor since a comparison of enzyme activities in the nonnecrotic and necrotic areas demonstrated much higher activities in the nonnecrotic areas. No increases in lysosomal enzyme activity were observed with time in Sarcoma 180, a tumor which does not metastasize. There was no change with time in primary Lewis lung tumor lactate dehydrogenase activity while a 7-fold increase in serum lactate dehydrogenase activity was observed in tumor-bearing mice. Mitochondrial succinate-2-(p-iodophenyl)-3-(p-nitrophenyl)-5-phenyltetrazolium reductase levels fell in the primary Lewis lung tumor as the tumor size increased. A positive correlation was observed between the time of the elevations of tumor lysosomal enzymes in Lewis lung carcinoma and the appearance of micro- and macrometastatic lesions in the lungs. The mechanisms accounting for the increased intratumoral lysosomal enzymes are unknown, but they may be related to macrophage infiltration or other tumor-host interactions which may facilitate the dissemination of tumor cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7427942

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Modification of the metastatic potential of tumor cells by drugs.

Authors:  K Takenaga
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

2.  The inflammatory reaction and malignant tumour development one may be bested by the other: ancient concepts and recent evidence.

Authors:  K W Stahl; G Mathé
Journal:  Agents Actions       Date:  1984-02

Review 3.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

4.  Isolation and characterization of low- and high-metastatic clones from murine RCT (Radiological, Chiba, and Toyama) sarcoma.

Authors:  H Matsui; S Tatezaki; H Tsuji; H Ochiai
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 5.  Glycosidases in cancer and invasion.

Authors:  R J Bernacki; M J Niedbala; W Korytnyk
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 6.  Cell detachment and metastasis.

Authors:  L Weiss; P M Ward
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

7.  Isolation and characterization of metastatic sublines from a murine transitional cell bladder carcinoma.

Authors:  B A Barut; J E Klaunig
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

8.  Modulation of the transport of a lysosomal enzyme by PDGF.

Authors:  E M Prence; J M Dong; G G Sahagian
Journal:  J Cell Biol       Date:  1990-02       Impact factor: 10.539

9.  Placental Leucine Aminopeptidase as a Potential Specific Urine Biomarker for Invasive Ovarian Cancer.

Authors:  Tetsuya Matsukawa; Shigehiko Mizutani; Kunio Matsumoto; Yukio Kato; Masato Yoshihara; Hiroaki Kajiyama; Kiyosumi Shibata
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

Review 10.  The tumor phenotype and the human gene map.

Authors:  N K Honey; T B Shows
Journal:  Cancer Genet Cytogenet       Date:  1983-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.